Ginkgo Bioworks DNA Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied?
- Ginkgo Bioworks (DNA) reported remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied of $127.4M in Q1 2026.
- How has Ginkgo Bioworks's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied changed year-over-year?
- Ginkgo Bioworks's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied increased by 2.9% year-over-year, from $123.8M to $127.4M.
- What is the long-term trend for Ginkgo Bioworks's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied has grown at a 45.9% compound annual growth rate (CAGR), from $20.7M to $136.8M.